SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-22-008141
Filing Date
2022-12-01
Accepted
2022-12-01 17:19:15
Documents
20
Period of Report
2022-11-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cns_8k.htm   iXBRL 8-K 43327
2 FORM OF WARRANT cns_ex0401.htm EX-4.1 115928
3 FORM OF PRE-FUNDED WARRANT cns_ex0402.htm EX-4.2 115765
4 FORM OF PLACEMENT AGENT WARRANT cns_ex0403.htm EX-4.3 119398
5 FORM OF SECURITIES PURCHASE AGREEMENT cns_ex1001.htm EX-10.1 227603
6 FORM OF PLACEMENT AGENCY AGREEMENT cns_ex1002.htm EX-10.2 188789
7 FORM OF WARRANT AMENDMENT AGREEMENT cns_ex1003.htm EX-10.3 8989
8 PRESS RELEASE DATED NOVEMBER 30, 2022 cns_ex9901.htm EX-99.1 12109
9 GRAPHIC image_001.jpg GRAPHIC 4519
  Complete submission text file 0001683168-22-008141.txt   1202294

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE cnsp-20221130.xsd EX-101.SCH 3230
11 XBRL LABEL FILE cnsp-20221130_lab.xml EX-101.LAB 34240
12 XBRL PRESENTATION FILE cnsp-20221130_pre.xml EX-101.PRE 22361
14 EXTRACTED XBRL INSTANCE DOCUMENT cns_8k_htm.xml XML 3718
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39126 | Film No.: 221439593
SIC: 2834 Pharmaceutical Preparations